In a retrospective Italian study that enrolled 50 CRC patients neurosurgically resected for secondary brain lesions, the overall HER-2 positivity of brain metastases was 12%, and a concordance rate of 89% between primary tumor and distant lesion was reported [87]. The gene discussed is ERBB2; the disease is colorectal carcinoma.